Bayer launches new LifeHub in Monheim concentrated on the Future of Agriculture in Europe
The newest LifeHub in the Bayer network will connect the company more nearly to the German invention ecosystem of scientists, experimenters, decision makers, and entrepreneurs Focus lies on dialogue and invention through open approaches that contribute to achieving the objects of the European Union’s Green Deal
As part of Bayer’s continuing fidelity to developing innovative results to the challenges facing growers, consumers and our earth, the company blazoned moment the sanctioned kick- off of the LifeHub Monheim, a unborn cooperation- concentrated installation located on the lot of Bayer’s global Crop Science Division headquarters in Monheim, Germany.
As the newest addition to Bayer’s global LifeHub network, LifeHub Monheim will bring together originators, entrepreneurs, and scientists from each over Europe to partake knowledge, experience and coffers that will help enable sustainable food security for the world’s growing population. To promote innovative scientific approaches and dialogue with society that contribute to achieving the objects of the European Union’s Green Deal, LifeHub Monheim will work with leading originators from the European open invention ecosystem, furnishing moxie and coffers for mates of all sizes. The Green Deal is the European Commission’s roadmap towards a net- zero carbon emigrations and indirect frugality in 2050.
“ The challenges that husbandry faces in feeding a growing population in malignancy of accelerating climate change and extreme rainfall events are bigger than anyone can break alone, ” said Bob Reiter, Head of Research and Development for the company’s Crop Science Division. “ Making sure that we’re a probative part of the invention ecosystem is a critical way to insure that new results for these issues get the support they need. Our global network of LifeHubs is an important way to connect with leading originators locally and to support where Bayer can help make the most impact. ”
The endless home of the new LifeHub is listed to be completed in different phases during the course of 2023 and 2024, but the mecca has formerly started erecting connections in Germany, especially in North Rhine- Westphalia, by hosting cooperative events from its interim installation.
In May 2022, the LifeHub joined entrepreneurs and start- ups with Bayer scientists in a launch- up pitch day concertedly organized with European Institute of Innovation, EIT Food. In November, a alternate pitch day is planned with “ High- Tech Gründerfonds ” a commanding German adventure capital investor for innovative technologies and business models. As part of the kick- off moment, Bayer hosted a gene editing council on the Monheim lot, bringing together leaders from around the world to bandy trends and discoveries in this fleetly advancing field.
“ erecting a community of originators starts by bringing people together, and that’s what LifeHub Monheim is each about, ” said Axel Trautwein, Head of Regulatory Science at Bayer’s Crop Science Division. “ From decision makers and fiscal coffers to scientists, the Bayer LifeHubs around the world make connections and brace coffers and moxie with those that need them. We ’re agitated to be showing so easily our commitment to the growing invention ecosystem of Germany and ca n’t stay to see what we discover together. ”
About Bayer
Bayer is a global enterprise with core capabilities in the life wisdom fields of health care and nutrition. Its products and services are designed to help people and the earth thrive by supporting sweats to master the major challenges presented by a growing and growing global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and produce value through invention and growth. The Bayer brand stands for trust, trustability and quality throughout the world. In financial 2021, the Group employed around,000 people and had deals of44.1 billion euros. R&D charges before special particulars amounted to5.3 billion euros.
Source link: https://www.bayer.com/
